CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating activities:
Net loss	$ (6,656,039)	$ (7,021,123)
Adjustments to reconcile net loss to net cash
Stock-based compensation expense	518,624	986,132
Depreciation expense	512,332	550,640
Amortization of mining rights	303,918	307,294
Accretion expense	248,291	249,016
Amortization of finance right-to-use assets - related party	126,296	0
Amortization of issuance costs and debt discount	28,912	25,407
Investment in other entities - Related Parties, net	10,866	214,975
Gain on sale of equipment	0	(400,000)
Issuance of common shares for services	0	43,800
Unrealized gain on short-term investments	4,455	26,819
Change in current assets and liabilities:
Receivables	(30,630)	0
Interest receivable	0	(47,542)
Due from related party	(40,000)	0
Inventories	(118,300)	0
Prepaid expenses and other current assets	18,619	(11,251)
Trade and non-trade payable	1,528,575	(254,784)
Accounts payable related party	(54,639)	763,054
Accrued expenses	(57,499)	(244,116)
Accrued litigation settlement	59,177	59,835
Accrued interest	2,429,722	0
Accrued interest on finance lease liability - related party	90,488	0
Operating lease assets and liabilities, net	3,916	(21,945)
Operating lease assets and liabilities, net - related party	(361,935)	23,752
Cash used in operating activities	(1,434,850)	(4,750,471)
Cash Flows from Investing activities:
Purchase of property and equipment, net of capitalized interest income and (expense)	158,499	(882,426)
Restricted investments purchased	(298,958)	(143,425,715)
Proceeds from maturity of restricted investments	151,205,321	0
Proceeds from sale of equipment	0	400,000
Proceeds from short-term investments, net	582,903	103,444
Cash used in provided by investing activities	151,647,765	(143,804,697)
Cash Flows from Financing activities:
Proceeds from convertible promissory note - related party	0	142,471
Proceeds from convertible promissory note	1,450,000	0
Proceeds received from other financing obligation	0	72,402
Proceeds from the exercise of stock option	0	156,898
Proceeds from tax exempt bonds, net	0	149,719,203
Repayments of other financing obligation	(1,373,201)	(1,857,897)
Cash provided by financing activities	76,799	148,233,077
Increase (decrease) in cash	150,289,714	(322,091)
Cash and cash equivalents, including restricted cash, beginning of period	4,113,329	5,077,560
Cash and cash equivalents, including restricted cash, end of period	154,403,043	4,755,469
SUPPLEMENTAL CASH FLOW INFORMATION
Common stock issued to settle accounts payable and accrued expenses	1,544,103	0
Acquisition of PPE through convertible promissory note - related party		53,664
Dividend-in-kind of Novustera, Inc. common stock to shareholders	$ 0	$ 1,361,788